Last reviewed · How we verify

NCT07086898: CGH

Impact of Adding Integrated Neuromuscular Inhibition Technique to Postural Correction Exercises in Patients With Cervicogenic Headache

Not yet recruiting NA Last updated 25 July 2025
What this trial tests

NA trial testing Integrated Neuromuscular Inhibition Technique in Cervicogenic Headache in 90 participants. Not yet recruiting.

Timeline
30 July 2025
Primary endpoint
25 February 2026
25 February 2026

Quick facts

Lead sponsorCairo University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment90
Start date30 July 2025
Primary completion25 February 2026
Estimated completion25 February 2026

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 60, any sex, with Cervicogenic Headache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

this study will be conducted to investigate the impact of adding integrated neuromuscular inhibition technique to postural correction exercises in patients with cervicogenic headache

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Integrated Neuromuscular Inhibition Technique

Trials testing the same drug.

Other recruiting trials for Cervicogenic Headache

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07086898.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing